History and update of HTLV infection in China

Virus Research

Volumn 191, Issue 1, 2014, Pages 134-137

  Du, Jialiang ^a   Chen, Changrong ^b   Gao, Jiamei ^a   Xie, Jinzhen ^b   Rong, Xia ^c   Xu, Xiaoxun ^d   Wang, Yongjun ^e   Wang, Fang ^f   Li, Jianbin ^g   Lu, Zhiming ^h   Guo, Weipeng ⁱ   Li, Guoliang ^j   Wang, Zhongying ^k   Xu, Dongfeng ^l   Weng, Jianfeng ^m   Zhao, Zhijian ⁿ   Weng, Wei ^o   Li, Haoru ^p   Du, Yong ^q   Li, Song ^r   Zhen, Chaohui ^s   Liu, Baolin ^t   Guo, Tai ^a   more..

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^b Xiamen Blood Center   (China)

^c Guangzhou Blood Center   (China)

^d Shenzhen Blood Center   (China)

^e BLOOD CENTER OF ZHEJIANG PROVINCE   (China)

^f Liaoning Blood Center   (China)

^g Henan Red Cross Blood Center   (China)

^h SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

ⁱ Urumqi Blood Center   (China)

^j Jiangxi Blood Center   (China)

^k Shanghai Blood Center   (China)

^l Ningde Blood Center   (China)

^m Putian Blood Center   (China)

ⁿ Zhangzhou Blood Center   (China)

^o Longyan Blood Center   (China)

^p Zhoushan Blood Center   (China)

^q Ningbo Blood Center   (China)

^r Jiaxing Blood Center   (China)

^s Taizhou Blood Station   (China)

^t Centeral Blood Station of Wenzhou   (China)

more..

Author keywords

China; History; HTLV infection; Update

Indexed keywords

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHINA; CONTROL STRATEGY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INDUSTRIALIZATION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; RISK FACTOR; GENETICS; HISTORY; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; PHYSIOLOGY; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

CHINA; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS;

EID: 84922378621     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.07.036     Document Type: Article

References (9)

1. Zeng Y., Lan X.Y., Fang J., Wang P.Z., Wang Y.R., Sui Y.F., Wang Z.T., Hu R.J., Hinuma Y. HTLV antibody in China. Lancet 1984, 1:799-800.
2. Chen Y.C., Wang C.H., Su I.J., Hu C.Y., Chou M.J., Lee T.H., Lin D.T., Chung T.Y., Liu C.H., Yang C.S. Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood 1989, 74:388-394.
3. Geng L., Zai N., Xiao Y., Song F., Tanaka A., Lou H., Sonoda S., Kanzaki T. Search for human T-lymphotropic virus type I carriers among northeastern Chinese. J. Dermatol. Sci. 1998, 18:30-34.
4. Cao F., Ji Y., Huang R., Lin S. Prevalence of antibodies to HTLV-I/II in blood donors and risk populations in South China. Vox Sang. 1998, 75:154.
5. Wang Y., Li X., Song A., Zhang C., Chen Y., Chen C., Lin Y., Shun L., Li L., Liu Y., Yang J., Yang B., Tang Q., Harrison T.J. Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China. J. Med. Virol. 2005, 76:613-618.
6. Ma Y., Zheng S., Wang N., Duan Y., Sun X., Jin J., Zang W., Li M., Wang Y., Zhao G. Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in central China. PLOS ONE 2013, 8:e66795.
7. Gessain A., Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front. Microbiol. 2012, 3:388.
8. Xie J.Z., Chen C.R., Zhang J., Ni H.Y., Ge S.X., Zhou J.J., Ou S.H., Zheng X.J., Ran P., Pei B. Quantitation of HTLV-I proviral load using real-time quantitative PCR with Taqman MGB probe. Bing Du Xue Bao 2009, 25(5):339-343. (article in Chinese).
9. Hino S., Katamine S., Miyata H., Tsuji Y., Yamabe T., Miyamoto T. Primary prevention of HTLV-I in Japan. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996, 13S:S15-S19.